Filing Details
- Accession Number:
- 0001654954-16-003244
- Form Type:
- 13G Filing
- Publication Date:
- 2016-10-31 18:22:01
- Filed By:
- Honig Barry C
- Company:
- Relmada Therapeutics Inc. (NASDAQ:RLMD)
- Filing Date:
- 2016-11-01
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Barry Honig | 0 | 0 | 0 | 0 | 0 | 0% |
| Southern Biotech, Inc | 0 | 0 | 0 | 0 | 0 | 0% |
Filing
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, DC
20549
SCHEDULE 13G
(Rule 13d-102)
(Amendment No. 2)
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO
RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT
TO
RULE
13d-2(b)
RELMADA
THERAPEUTICS INC.
(Name of
Issuer)
COMMON STOCK,
$0.001 PAR VALUE PER SHARE
(Title
of Class of Securities)
75955J1204
(CUSIP
Number)
Copy
to:
Barry
Honig
555
South Federal Highway #450
Boca Raton, FL
33432
(Name,
Address and Telephone Number of Person
Authorized to
Receive Notices and Communications)
October 31,
2016
(Date
of Event Which Requires Filing of This Statement)
Check
the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ]
Rule 13d-1(b)
[ x]
Rule 13d-1(c)
[ ]
Rule 13d-1(d)
(Page 1
of 6 Pages)
| CUSIP
No. 75955J204 |
| 1 | NAME OF
REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY) Barry
Honig |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP*
(a)
☐
(b) ☐ |
| 3 | SEC USE
ONLY |
| 4 | CITIZENSHIP OR
PLACE OF ORGANIZATION United
States |
| NUMBER
OF SHARES | 5 | SOLE
VOTING POWER 0 |
| BENEFICIALLY OWNED
BY | 6 | SHARED
VOTING POWER 0 |
| EACH REPORTING | 7 | SOLE
DISPOSITIVE POWER 0 |
| PERSON
WITH | 8 | SHARED
DISPOSITIVE POWER 0 |
| 9 | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| 10 | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0% |
| 12 | TYPE OF
REPORTING PERSON* IN |
| CUSIP
No. 75955J204 |
| 1 | NAME OF
REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY) Southern Biotech,
Inc. |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP*
(a) ☐
(b) ☐ |
| 3 | SEC USE
ONLY |
| 4 | CITIZENSHIP OR
PLACE OF ORGANIZATION Nevada |
| NUMBER
OF SHARES | 5 | SOLE
VOTING POWER 0 |
| BENEFICIALLY OWNED
BY | 6 | SHARED
VOTING POWER 0 |
| EACH REPORTING | 7 | SOLE
DISPOSITIVE POWER 0 |
| PERSON
WITH | 8 | SHARED
DISPOSITIVE POWER 0 |
| 9 | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 |
| 10 | CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS) |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 0
% |
| 12 | TYPE OF
REPORTING PERSON* OO |
| Item
1(a) | |
Name of
Issuer:
Relmada
Therapeutics, Inc.
Item
1(b).
Address of Issuer's
Principal Executive Offices:
275
Madison Avenue, Suite 702
New
York, New York 10016
Item
2(a).
Name of Person
Filing.
The
statement is filed on behalf of Barry Honig and Southern Biotech, Inc. (collectively the
“Reporting Persons”).
Item
2(b).
Address of
Principal Business Office or, if None, Residence.
555
South Federal Highway #450, Boca Raton, FL 33432
Item
2(c).
Citizenship.
United
States/Nevada
Item
2(d).
Title of Class of
Securities.
Common
Stock, $0.001 par value per share.
Item
2(e).
CUSIP
Number.
7955J1204
| Item
3. | Type of
Person |
Not
applicable.
| Item
4. | Ownership. |
(a)
Amount beneficially owned: 0
(b)
Percent of class: 0%
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote: 0
(ii)
Shared power to vote or to direct the vote: 0
(iii)
Sole power to dispose or to direct the disposition of:
0
(iv)
Shared power to dispose or to direct the disposition of:
0
| Item
5. | Ownership of Five
Percent or Less of a Class. |
Not
applicable.
Item
6.
Ownership of More
than Five Percent on Behalf of Another Person.
Not
Applicable
Item
7.
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported by the Parent Holding Company.
Not
applicable.
Item
8.
Identification and
Classification of Members of the Group.
Not
applicable.
Item
9.
Notice of
Dissolution of Group.
Not
applicable.
Item
10.
Certifications.
By
signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or
effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
| | | | |
| Date:
October 31, 2016 | By: | /s/ Barry
Honig | |
| | | Barry
Honig | |
| | | | |
| | | | |
| | Southern
Biotech, Inc. | | |
| Date:
October 31, 2016 | By: | /s/ Barry
Honig | |
| | | Barry
Honig, President | |